Showing results (1-10 of 298) with videos related to
Sort By:
Pageof 30
Antiviral Research|January 29, 2014
What is the future of ribavirin therapy for hepatitis C?Christopher Koh, T Jake LiangHepatology (Baltimore, Md.)|August 5, 2010
The association of genetic variability in patatin-like phospholipase domain-containing protein 3 (PNPLA3) with histological severity of nonalcoholic fatty liver diseaseYaron Rotman, Christopher Koh, Joseph M Zmuda, et al.Hepatology (Baltimore, Md.)|June 19, 2013
AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendationsChristopher Koh, Xiongce Zhao, Niharika Samala, et al.Nature Medicine|July 10, 2013
Current progress in development of hepatitis C virus vaccinesT Jake LiangGastroenterology|February 22, 2017
Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future DirectionsRohit Loomba, T Jake LiangAntiviral Therapy|March 8, 2006
Novel approaches to new therapies for hepatitis B virus infectionRohit Loomba, T Jake LiangGastroenterology|May 1, 2020
Is SARS-CoV-2 Also an Enteric Pathogen With Potential Fecal-Oral Transmission? A COVID-19 Virological and Clinical ReviewSiyuan Ding, T Jake LiangHepatology (Baltimore, Md.)|October 28, 2003
Exploring the biological basis of hepatitis B e antigen in hepatitis B virus infectionDavid Milich, T Jake LiangGastroenterology|October 28, 2004
Pathogenesis of hepatitis C-associated hepatocellular carcinomaT Jake Liang, Theo HellerPageof 30